Daily Newsletter

09 October 2023

Daily Newsletter

09 October 2023

Paradigm, Bristol Myers Squibb partner for clinical trial operational model

Bristol Myers will be able to enrol patients through providers across Paradigm Network of health systems.

October 09 2023

Paradigm has partnered with Bristol Myers Squibb to create an end-to-end clinical trial operational model for design, patient recruitment and data collection.

Initially, the collaboration will focus on oncology and will further expand to cover other therapeutic areas.

In this partnership, Bristol Myers Squibb will be able to enrol patients through providers across the Paradigm Network of health systems who serve different groups.

These health systems already utilise the software from Paradigm to reduce the burden of clinical trial recruitment as well as operations.

The administrative challenges of running clinical trials have led to limited accessibility and uneven patient enrolment.

Presently, less than 5% of cancer patients participate in clinical trials during their treatment journeys.

This process delayed the introduction of new treatments on the market and millions of individuals who may benefit from trials are not able to take part.

In response to this challenge, Paradigm has decided to create a new clinical trial operating ecosystem.

Paradigm and Bristol Myers Squibb are designing trials whose protocol requirements meet the practical constraints of community health provider organisations.

Initially, Paradigm introduced its clinical trial software platform to community healthcare providers, who provided care for patients with cancer and other severe conditions, as well as served populations that mirror the overall US demographics.

Paradigm CEO Kent Thoelke said: “We fundamentally believe every patient deserves the best possible care, which should include the evaluation for participation in clinical research. Working with a leader like Bristol Myers Squibb helps scale equitable access for patients today.

“In the process, we aim to help Bristol Myers Squibb speed up recruitment, attract a more diverse patient population, reduce provider burden and more rapidly complete trials to increase access to potentially helpful therapies in the future.”

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors


Sign up to the newsletter: In Brief

Your corporate email address *
First name *
Last name *
Company name *
Job title *
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.